Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.33%55.116.5%$166.92m
CTLTCatalent, Inc. 0.23%77.652.1%$112.51m
VRXValeant Pharmaceuticals International, Inc. -0.12%17.3914.1%$102.33m
JAZZJazz Pharmaceuticals Plc 0.64%106.222.4%$77.13m
UTHRUnited Therapeutics Corp. 0.69%116.7614.3%$67.93m
BHCBausch Health Cos., Inc. -0.40%17.340.0%$65.20m
ICPTIntercept Pharmaceuticals, Inc. -0.44%42.9416.8%$62.69m
PCRXPacira Biosciences, Inc. -0.05%55.5610.3%$54.75m
AXSMAxsome Therapeutics, Inc. 1.41%77.821.9%$48.86m
ZGNXZogenix, Inc. -0.04%26.487.5%$47.23m
PRGOPerrigo Co. Plc 0.14%55.616.8%$43.57m
MYOKMyoKardia, Inc. 0.38%90.961.8%$43.37m
GWPHGW Pharmaceuticals Plc 2.05%134.916.2%$42.08m
ARGXargenx SE -0.88%248.610.0%$41.67m
ICLRICON plc 0.40%172.484.3%$37.48m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.